Program to help individuals with psychotic and bipolar disorders manage stigma and disclosure
Official title: Evaluation of a Norwegian Adaptation of the Honest Open Proud Program for Adults With Psychotic and Bipolar Disorders in an Outpatient Setting
Run by Oslo University Hospital · NCT06384755 · Data updated 2026-11-12
This study is testing a new program to help adults with psychotic and bipolar disorders learn how to handle stigma and decide when to share their mental health challenges with others.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Oslo University Hospital Academic / other |
| Locations | 2 sites (Oslo and 1 other locations) |
| Status | Recruiting |
| Started | April 20, 2024 |
| Main results expected | December 31, 2024 |
| Study ends | December 31, 2026 |
| Registry record updated | May 2, 2024 |
| Trial ID | NCT06384755 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 to 65 diagnosed with psychotic or bipolar disorders who experience difficulties with stigma and disclosure.
✕Probably not a fit
Patients with intellectual disabilities or organic disorders may not benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot study evaluates the feasibility, acceptability, and efficacy of a Norwegian adaptation of the Honest Open Proud program for adults with psychotic and bipolar disorders in an outpatient setting. The program aims to assist individuals in making informed decisions about disclosing their mental health challenges, addressing the stigma associated with these conditions. By facilitating peer support and strategic disclosure, the intervention seeks to improve mental health outcomes and reduce social isolation. Participants will engage in group-based sessions led by trained facilitators, focusing on the complexities of stigma and disclosure.
Why it matters
Potential benefit: If successful, this program could enhance the mental health and social support of individuals with psychotic and bipolar disorders by providing them with tools to navigate stigma.
How similar studies have gone: Other studies have shown success with similar peer-led interventions aimed at reducing stigma and improving mental health outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed current psychotic (F 20) or bipolar disorder (F 30) according to International Classification of Diseases 10th Revision (ICD-10) * Age 18 to 65 * Ability to provide written informed consent. * Fluent in Norwegian (needed for self-report measures) * Experience difficulties with stigma and disclosure regarding mental illness. Exclusion Criteria: * Intellectual disability * Organic disorders
Where it's running
-
Nydalen DPS, Division of Mental Health and Addiction, Oslo University Hospital
Oslo, Norway Recruiting -
Søndre Oslo DPS, Division of Mental Health and Addiction, Oslo University Hospital
Oslo, Norway Not yet recruiting
Study contacts
- Principal investigator: Carmen Simonsen, PhD — Department of Psychology, University of Oslo
- Study coordinator: Carmen Simonsen, PhD
- Email: carmen.simonsen@psykologi.uio.no
- Phone: 0047 90988741
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cognitive Behavioral Therapy for Chronic Pain in Veterans with Serious Mental Illness
This study will test whether Cognitive Behavioral Therapy for Chronic Pain (CBT-CP) helps Veterans with serious mental illness and chronic low back pain reduce pain-related interference and improve quality of life.
-
Theta-Burst Transcranial Magnetic Stimulation for Treatment-Resistant Auditory Hallucinations
This study tests whether theta-burst transcranial magnetic stimulation can lessen persistent auditory verbal hallucinations in adults with schizophrenia-spectrum or psychotic disorders who have not responded to antipsychotic meds.
-
Small Soteria-inspired unit vs. standard closed ward for acute psychosis
A randomized or semi-randomized comparison tests whether a small Soteria-style inpatient unit improves outcomes for adults with acute psychosis compared to a conventional closed psychiatric ward.
-
Accelerated Brain Stimulation for Young People at Risk of Psychosis
This study tests a five-day accelerated brain-stimulation treatment to see if it is safe and tolerable for young people at risk for psychosis and to explore biomarkers that might show whether it works.
-
One-Page Truth-Telling Aid to Guide Cancer Discussions
A one-page tool is tested to help doctors quickly understand a cancer patient’s information preferences before a consultation.
-
Effects of comorbidity on people with severe mental illness
This study tests how having both alcohol/substance use and a severe mental illness affects hospitalizations, medications, and social participation among adults followed at a mental health center.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.